| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/22/1999 | WO1999036079A1 A noncleavable fas ligand |
| 07/22/1999 | WO1999036078A1 Analgesic from snake venom |
| 07/22/1999 | WO1999030157A3 Neuropilins in methods for diagnosis and prognosis of cancer |
| 07/22/1999 | WO1999028482A3 Single-chain recombinant complexes of hepatitis c virus ns3 protease and ns4a cofactor peptide |
| 07/22/1999 | WO1999028439A3 Erythrovirus and its applications |
| 07/22/1999 | WO1999027958A3 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 07/22/1999 | WO1999027097A3 CLONING OF A TETRODOTOXIN-RESISTANT SODIUM CHANNEL α-SUBUNIT |
| 07/22/1999 | WO1999025721B1 Detection and treatment of retinal degenerative disease |
| 07/22/1999 | WO1999024835A3 An immunoassay for procollagen-iii-c-terminal propeptide |
| 07/22/1999 | WO1999024553A8 X-ray crystal comprising hiv-1 gp120 |
| 07/22/1999 | WO1999024052A3 Use of protein h as cytostatic agent |
| 07/22/1999 | WO1999012971A3 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 07/22/1999 | WO1999012948A3 Protein-coated polyribonucleic acids, method for the production thereof, and use of the same |
| 07/22/1999 | WO1998055495B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 07/22/1999 | WO1998044945A9 Non-infectious, protease defective hiv particles and nucleic acid molecules encoding therefor |
| 07/22/1999 | WO1998008388A8 Pesticidal agents |
| 07/22/1999 | WO1997044469A8 Multiple epitope fusion protein |
| 07/22/1999 | DE19801780A1 Transgenic non-human mammal containing p53 knock-in gene, useful as model for carcinogenesis |
| 07/22/1999 | DE19753681A1 Erythropoietin composition has a highly specific activity |
| 07/22/1999 | DE19718640A1 Protein derived from Anemonia useful in gene technology and molecular biology |
| 07/22/1999 | CA2318663A1 Methods and compositions for gene delivery |
| 07/22/1999 | CA2318660A1 Lh-receptor gene promoter for tissue-specific gene expression |
| 07/22/1999 | CA2318575A1 Feline immunodeficiency virus gene therapy vectors |
| 07/22/1999 | CA2318525A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | CA2318439A1 Vaccine composition for herpes simplex virus and methods of using |
| 07/22/1999 | CA2318402A1 Regulation of biological events using multimeric chimeric proteins |
| 07/22/1999 | CA2318363A1 Fatty acid transport proteins |
| 07/22/1999 | CA2318358A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | CA2318284A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 07/22/1999 | CA2318279A1 Analgesic from snake venom |
| 07/22/1999 | CA2318156A1 Mmsc1 - an mmac1 interacting protein |
| 07/22/1999 | CA2317941A1 Adenoviral vectors with modified capsid proteins |
| 07/22/1999 | CA2317815A1 Neisseria meningitidis antigens |
| 07/22/1999 | CA2317810A1 Human chemokine and its use for detection and treatment of breast disease |
| 07/22/1999 | CA2317449A1 Nucleic acids encoding a functional human purinoreceptor p2x3 and methods of production and use thereof |
| 07/22/1999 | CA2317392A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | CA2317026A1 Use of a proline-rich sequence to improve the fusogenic character of retroviral envelopes |
| 07/22/1999 | CA2315299A1 Fatty acid synthase mrna binding protein |
| 07/21/1999 | EP0930366A2 Binding domains in delta proteins |
| 07/21/1999 | EP0930365A2 Binding domains in serrate protein |
| 07/21/1999 | EP0930364A1 TWIK-1 related two domains potassium channel |
| 07/21/1999 | EP0930363A2 Immobilization of cohesive or adhesive cells and use thereof |
| 07/21/1999 | EP0929812A1 Diagnostic agent and method to determine pregnancy in ruminants |
| 07/21/1999 | EP0929811A1 ASSAY FOR THE DETECTION OF ANTIBODIES AGAINST p53 |
| 07/21/1999 | EP0929694A1 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| 07/21/1999 | EP0929691A2 Methods and compositions for identifying receptor effectors |
| 07/21/1999 | EP0929687A1 Mammary gland-specific promoters |
| 07/21/1999 | EP0929686A1 Early seed 5' regulatory sequence |
| 07/21/1999 | EP0929685A2 Transgenic plants with enhanced sulfur amino acid content |
| 07/21/1999 | EP0929684A2 Phospholipase d and dna sequences |
| 07/21/1999 | EP0929683A1 DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE |
| 07/21/1999 | EP0929679A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| 07/21/1999 | EP0929678A2 Protein and peptide vaccines for inducing mucosal immunity |
| 07/21/1999 | EP0929677A2 Method for producing recombinants intended for use in a complete malaria antigene gp190/msp1 |
| 07/21/1999 | EP0929675A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/21/1999 | EP0929674A2 HUMAN Bad POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE |
| 07/21/1999 | EP0929673A2 Tumor proteins |
| 07/21/1999 | EP0929672A1 Human gtp binding protein gamma-3 |
| 07/21/1999 | EP0929670A1 P-selectin ligand proteins |
| 07/21/1999 | EP0929669A1 Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis |
| 07/21/1999 | EP0929668A1 Modulators of brca1 activity |
| 07/21/1999 | EP0929667A1 Hypertension markers |
| 07/21/1999 | EP0929664A1 Hematopoietic stem cells and methods for generating such cells |
| 07/21/1999 | EP0929663A1 Method of increasing growth and yield in plants |
| 07/21/1999 | EP0929579A1 Monoclonal antibodies against a human act and serine protease complex |
| 07/21/1999 | EP0929577A1 Stabilized proteinaceous protease inhibitors and variants thereof |
| 07/21/1999 | EP0929576A1 Glp-2 derivatives |
| 07/21/1999 | EP0929575A1 Novel human growth factors |
| 07/21/1999 | EP0929574A1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS |
| 07/21/1999 | EP0929569A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 07/21/1999 | EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders |
| 07/21/1999 | EP0929564A1 High level expression of proteins |
| 07/21/1999 | EP0929316A1 Novel product and process for t lymphocyte veto |
| 07/21/1999 | EP0929300A2 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 07/21/1999 | EP0929211A1 THE PROMOTER (FLt) FOR THE FULL-LENGTH TRANSCRIPT OF PEANUT CHLOROTIC STREAK CAULIMOVIRUS (PC1SV) |
| 07/21/1999 | EP0832095A4 A method of cross-linking amino acid-containing polymers using photoactivatable chemical cross-linkers |
| 07/21/1999 | EP0629239B1 Insecticidal toxins from the parasitic wasp bracon hebetor |
| 07/21/1999 | EP0463064B1 Neuronal nicotinic acetylcholine receptor compositions containing the beta4 subunit |
| 07/21/1999 | CN1223732A Small molecule mimetics of erythropoietin |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 07/21/1999 | CN1223687A Isolation of the biosythesis genes for pseudo-oligosaccharides from streptomyces glaucescens gla.o and their use |
| 07/21/1999 | CN1223685A Modulators of tissue regeneration |
| 07/21/1999 | CN1223664A Serine protease inhibitors |
| 07/21/1999 | CN1223663A Transcription factor |
| 07/21/1999 | CN1223660A Method and compounds for curing diseases caused by mutations |
| 07/21/1999 | CN1223586A Recombinant vaccine for diseases caused by encapsulated organisms |
| 07/21/1999 | CN1223549A Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 07/21/1999 | CN1223266A Thymosin alpha-1 derivatives |
| 07/20/1999 | US5925808 Stably transforming first plant cell with dna sequence comprising gene whose expression results in altered plant phenotype, stably transforming second plant cell with second dna sequence comprising second gene, regenerating, hybridizing |
| 07/20/1999 | US5925803 Testing method using transgenic mice expressing an oncogene |
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925751 Human cytomegalovirus DNA sequences |
| 07/20/1999 | US5925750 Nucleic acid encoding polypeptide of a growth factor receptor family |
| 07/20/1999 | US5925748 DNA diagnostics for glaucoma |
| 07/20/1999 | US5925742 Protein affecting KATP channels |
| 07/20/1999 | US5925740 Antibodies to receptor for oncostatin M |
| 07/20/1999 | US5925737 Whey protein fractionation using high pressure or supercritical carbon dioxide |
| 07/20/1999 | US5925736 Collagen-based methods and formulations for the treatment of arthritis |
| 07/20/1999 | US5925735 Hematopoietic cytokine receptor |
| 07/20/1999 | US5925734 The viral proteins also have superantigen-like activity, and inhibit ebv infection. |